Merger and acquisition (M&A) deals among contract research organizations (CROs) have always occurred. But the last few years have seen an unprecedented increase, and industry experts say the trend isn’t slowing down. In 2021 alone, 50 CROs closed…
The evolution toward decentralized clinical trials has benefitted the pharmaceutical and biotech industries in various ways. Thanks in part to this trend, patient populations are more diverse, studies offer improved patient retention, and data can be collected without in-person…
